MHRA Grants Conditional Marketing Authorisation for Tepkinly[®]▼(epcoritamab) as a Bispecific Treatment for Adults with Relapsed or Refractory DLBCL After Two or More Lines of Systemic Therapy
PRESS RELEASE - For UK consumer, medical and trade media only · Diffuse large B-cell lymphoma (DLBCL) is an aggressive sub-type of non-Hodgkin’s lymphoma, with nearly 5,500 new diagnoses in the UK each year[1] · Bispecific antibodies represent a new class of therapies that work by introducing a local immune cell to a cancer cell, enabling the immune cell to attack and destroy the cancer[2] · As the first and only subcutaneous bispecific injection, epcoritamab could offer eligible patients an additional treatment option[3] MAIDENHEAD, UK, [23 October 2023] – AbbVie (NYSE:
(Stockholm, Sweden – October 24, 2023) – In response to long-standing demand from its clients, Advania is now launching a pioneering IT equipment recycling center to address widespread waste management issues in the IT sector. The facility's core function is to repair and refurbish used IT equipment, revitalising it to optimum condition before re-entering the market.“This initiative underlines our commitment to promoting sustainability and responsible resource management within the IT sector,” says Group CEO Hege Støre, who views this as a pressing issue long ignored by the industry.